CCM
Cinctive Capital Management Portfolio holdings
AUM
$1.79B
1-Year Return
33.04%
This Quarter Return
+8.61%
1 Year Return
+33.04%
3 Year Return
+118.69%
5 Year Return
+239.8%
10 Year Return
–
AUM
$1.74B
AUM Growth
-$120M
(-6.5%)
Cap. Flow
-$210M
Cap. Flow
% of AUM
-12.07%
Top 10 Holdings %
Top 10 Hldgs %
13.87%
Holding
527
New
157
Increased
86
Reduced
92
Closed
168
Top Buys
| 1 |
BKV
BKV Corporation
BKV
|
$21M |
| 2 |
Kyndryl
KD
|
$20.2M |
| 3 |
Kellanova
K
|
$19M |
| 4 |
Nextracker
NXT
|
$16.6M |
| 5 |
Sempra
SRE
|
$15.9M |
Top Sells
| 1 |
Wells Fargo
WFC
|
$25.1M |
| 2 |
Ares Management
ARES
|
$24.7M |
| 3 |
Kinder Morgan
KMI
|
$22.5M |
| 4 |
Agilent Technologies
A
|
$21.3M |
| 5 |
Humana
HUM
|
$20.5M |
Sector Composition
| 1 | Healthcare | 20.25% |
| 2 | Technology | 16.98% |
| 3 | Consumer Discretionary | 12.55% |
| 4 | Industrials | 11.22% |
| 5 | Financials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Revolution Medicines
RVMD
$7.57B
| $2.42M | 0.13% |
53,361
+30,430
| +133% | +$1.38M |
|
202
Tesla
TSLA
$1.13T
| $2.4M | 0.13% |
9,174
+2,174
| +31% | +$569K |
|
203
Brixmor Property Group
BRX
$8.63B
| $2.39M | 0.13% |
85,862
-36,745
| -30% | -$1.02M |
|
204
Frontline
FRO
$4.93B
| $2.39M | 0.13% |
104,557
+57,206
| +121% | +$1.31M |
|
205
3M
MMM
$82.7B
| $2.38M | 0.13% |
+17,376
| New | +$2.38M |
|
206
Newmont
NEM
$83.7B
| $2.37M | 0.13% |
44,254
-80,124
| -64% | -$4.28M |
|
207
Nurix Therapeutics
NRIX
$758M
| $2.36M | 0.13% |
+105,228
| New | +$2.36M |
|
208
Jacobs Solutions
J
$17.4B
| $2.33M | 0.13% |
17,959
-1,018
| -5% | -$132K |
|
209
Revvity
RVTY
$10.1B
| $2.31M | 0.13% |
+18,068
| New | +$2.31M |
|
210
Regions Financial
RF
$24.1B
| $2.29M | 0.12% |
98,027
-440,459
| -82% | -$10.3M |
|
211
Federal Realty Investment Trust
FRT
$8.86B
| $2.26M | 0.12% |
+19,670
| New | +$2.26M |
|
212
Insmed
INSM
$30.7B
| $2.24M | 0.12% |
30,706
-114,851
| -79% | -$8.38M |
|
213
Avidity Biosciences
RNA
$6.48B
| $2.18M | 0.12% |
47,554
-35,808
| -43% | -$1.64M |
|
214
Cenovus Energy Inc. Warrants (each warrant entitles the holder to purchase one common share at an exercise price of C$6.54 per share)
CVE.WS
| $2.16M | 0.12% |
181,700
| – | – |
|
215
Salesforce
CRM
$239B
| $2.15M | 0.12% |
+7,868
| New | +$2.15M |
|
216
Vera Therapeutics
VERA
$1.54B
| $2.14M | 0.12% |
48,500
+13,728
| +39% | +$607K |
|
217
BioCryst Pharmaceuticals
BCRX
$1.74B
| $2.08M | 0.11% |
+273,959
| New | +$2.08M |
|
218
Take-Two Interactive
TTWO
$44.2B
| $2.05M | 0.11% |
+13,346
| New | +$2.05M |
|
219
Burlington
BURL
$18.4B
| $1.98M | 0.11% |
+7,527
| New | +$1.98M |
|
220
Northrop Grumman
NOC
$83.2B
| $1.97M | 0.11% |
+3,738
| New | +$1.97M |
|
221
Permian Resources
PR
$9.75B
| $1.93M | 0.11% |
+141,540
| New | +$1.93M |
|
222
Zillow
Z
$21.3B
| $1.92M | 0.1% |
30,001
+8,001
| +36% | +$511K |
|
223
Dorman Products
DORM
$5B
| $1.91M | 0.1% |
+16,856
| New | +$1.91M |
|
224
NextNav
NN
$2.14B
| $1.89M | 0.1% |
252,952
| – | – |
|
225
Akero Therapeutics
AKRO
$3.58B
| $1.87M | 0.1% |
+65,307
| New | +$1.87M |
|